Moreover, the abnormally high expression of fructose-bisphosphatase 1 (FBP1), a downstream glycolysis enzyme and tumor suppressor which was recognized as a glycolysis inhibitor inhibits the invasion and metastasis of breast cancer (Shi et al., 2017). Here, FBP1 is linked to neoplasm.